SEC Form 4 · accession 0001237899-15-000068
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas S McCorkle
Officer — VP Controller and Asst Treasur
Period of report
Dec 29, 2015
Accepted (ET)
Dec 29, 2015 · 7:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 29, 2015 | M | 3,954 | $52.03 | A | 10,820 | D | |
| Common Stock | Dec 29, 2015 | S | 3,954 | $552.08 | D | 6,866 | D | |
| Common Stock | holding | — | — | — | 4,129 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $52.03 | Dec 29, 2015 | M | 3,954 | D | — | Dec 16, 2021 | Common Stock | 3,954 | 0 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.